These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 18191242)

  • 1. The use of different evidence-based medications and 5-year survival after an acute coronary syndrome: an observational study.
    Wong CK; Tang EW; Herbison P
    Int J Cardiol; 2009 Feb; 132(2):197-202. PubMed ID: 18191242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival over 5 years in the initial hospital survivors with acute coronary syndrome: a comparison between a community hospital and a tertiary hospital in New Zealand.
    Wong CK; Tang EW; Herbison P
    N Z Med J; 2007 Sep; 120(1261):U2713. PubMed ID: 17853934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic interactions between statins and in-hospital revascularisation on the outcome of acute coronary syndrome.
    Wong CK; Tang EW; Herbison P
    Heart Lung Circ; 2009 Aug; 18(4):262-5. PubMed ID: 19167924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of use of combination evidence-based medical therapy after acute coronary syndromes on long-term outcomes.
    Lahoud R; Howe M; Krishnan SM; Zacharias S; Jackson EA
    Am J Cardiol; 2012 Jan; 109(2):159-64. PubMed ID: 22011560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation between blood pressure at hospital discharge after an acute coronary syndrome and long-term survival.
    Wong CK; Herbison P; Tang EW
    Am J Cardiol; 2008 May; 101(9):1239-41. PubMed ID: 18435950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials.
    Wong CK; Newby LK; Bhapker MV; Aylward PE; Pfisterer M; Alexander KP; Armstrong PW; Hochman JS; Van de Werf F; Califf RM; White HD;
    Am Heart J; 2007 Aug; 154(2):313-21. PubMed ID: 17643582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of long-term use of evidence-based therapies after non-ST-segment elevation acute coronary syndrome. The S-Témoin survey.
    Danchin N; Diévart F; Thébaut JF; Grenier O; Mihci E; Herrmann MA; Ferrières J
    Int J Cardiol; 2009 Mar; 133(1):32-40. PubMed ID: 18375000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of evidence-based cardiac medication on short- and long-term mortality in 7,567 acute coronary syndrome patients in the Gulf RACE-II registry.
    Al-Zakwani I; Sulaiman K; Al Za'abi M; Panduranga P; Al-Habib K; Asaad N; Al Motarreb A; Hersi A; Al Faleh H; Al Saif S; Almahmeed W; Amin H; Alsheikh-Ali A; Al Lawati J; Al Suwaidi J
    Int J Clin Pharmacol Ther; 2012 Jun; 50(6):418-25. PubMed ID: 22541748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y; Gao R; Patel A; Su S; Gao W; Hu D; Huang D; Kong L; Qi W; Wu Y; Yang Y; Turnbull F;
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC; Tu JV; Ko DT; Alter DA
    CMAJ; 2008 Oct; 179(9):901-8. PubMed ID: 18936455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial.
    Mahaffey KW; Yang Q; Pieper KS; Antman EM; White HD; Goodman SG; Cohen M; Kleiman NS; Langer A; Aylward PE; Col JJ; Reist C; Ferguson JJ; Califf RM;
    J Gen Intern Med; 2008 Mar; 23(3):310-6. PubMed ID: 18196350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary treatment and adherence to guidelines in women and men with acute coronary syndromes.
    Moriel M; Tzivoni D; Behar S; Zahger D; Hod H; Hasdai D; Sandach A; Gottlieb S
    Int J Cardiol; 2008 Dec; 131(1):97-104. PubMed ID: 18222551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-blockers and statins are individually associated with reduced mortality in patients undergoing noncardiac, nonvascular surgery.
    Noordzij PG; Poldermans D; Schouten O; Schreiner F; Feringa HH; Dunkelgrun M; Kertai MD; Boersma E
    Coron Artery Dis; 2007 Feb; 18(1):67-72. PubMed ID: 17172933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute coronary syndrome emergency treatment strategies: Improved treatment and reduced mortality in patients with acute coronary syndrome using guideline-based critical care pathways.
    Corbelli JC; Janicke DM; Cziraky MJ; Hoy TA; Corbelli JA
    Am Heart J; 2009 Jan; 157(1):61-8. PubMed ID: 19081398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of in-hospital revascularization on survival in patients with non-ST-elevation acute coronary syndrome and congestive heart failure.
    Steg PG; Kerner A; Van de Werf F; López-Sendón J; Gore JM; Fitzgerald G; Feldman LJ; Anderson FA; Avezum A;
    Circulation; 2008 Sep; 118(11):1163-71. PubMed ID: 18725494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of medical noncompliance and long-term adverse outcomes, after myocardial infarction in a minority and uninsured population.
    Amin AP; Mukhopadhyay E; Nathan S; Napan S; Kelly RF
    Transl Res; 2009 Aug; 154(2):78-89. PubMed ID: 19595439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes.
    Gislason GH; Rasmussen JN; Abildstrom SZ; Schramm TK; Hansen ML; Buch P; Sørensen R; Folke F; Gadsbøll N; Rasmussen S; Køber L; Madsen M; Torp-Pedersen C
    Circulation; 2007 Aug; 116(7):737-44. PubMed ID: 17646585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical presentation and outcomes of acute coronary syndromes in the gulf registry of acute coronary events (Gulf RACE).
    Zubaid M; Rashed WA; Al-Khaja N; Almahmeed W; Al-Lawati J; Sulaiman K; Al-Motarreb A; Amin H; Al-Suwaidi J; Al-Habib K
    Saudi Med J; 2008 Feb; 29(2):251-5. PubMed ID: 18246236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
    Setoguchi S; Glynn RJ; Avorn J; Mittleman MA; Levin R; Winkelmayer WC
    J Am Coll Cardiol; 2008 Apr; 51(13):1247-54. PubMed ID: 18371553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.